Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • From the Analyst's Couch
  • Published:

Therapies for Alzheimer's disease

Nature Reviews Drug Discovery volume 6, pages 341–342 (2007)Cite this article

However, the number of therapeutic options for AD remains severely limited. Currently marketed drugs for AD do not prevent or reverse this disease and are approved only for the management of symptoms. Driven by the clear unmet medical need and a better understanding of the biology and pathophysiology of AD, the number of drugs in development for this indication has increased dramatically in recent years.

Current therapies

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: US sales of marketed AD drugs.

References

  1. Mount, C. & Downton, C. Alzheimer's disease: progress or profit? Nature Med. 12, 780–784 (2006).

    Article  CAS  Google Scholar 

  2. Klafki, H. -W. et al. Therapeutic approaches to Alzheimer's disease. Brain 129, 2840–2855 (2006).

    Article  Google Scholar 

  3. Masters, C. L. & Beyreuther, K. Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Aβ amyloid pathway. Brain 129, 2823–2839 (2006).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. a division of Leerink Swann, Irena Melnikova, Ph.D., is a director at MEDACorp, One Federal Street, Boston, Massachusetts 02110, USA. irenam@medacorp.com,

    Irena Melnikova

Authors
  1. Irena Melnikova
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Melnikova, I. Therapies for Alzheimer's disease. Nat Rev Drug Discov 6, 341–342 (2007). https://doi.org/10.1038/nrd2314

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd2314

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing